Cyclooxygenase-2-mediated regulation of Kupffer cell interleukin-6 production following trauma-hemorrhage and subsequent sepsis

被引:36
作者
Knöferl, MW
Diodato, MD
Schwacha, MG
Cioffi, WG
Bland, KI
Chaudry, IH
机构
[1] Univ Alabama, Surg Res Ctr, Birmingham, AL 35294 USA
[2] Brown Univ, Sch Med, Surg Res Ctr, Providence, RI 02903 USA
[3] Brown Univ, Sch Med, Dept Surg, Providence, RI 02903 USA
[4] Rhode Isl Hosp, Surg Res Ctr, Providence, RI 02903 USA
[5] Rhode Isl Hosp, Dept Surg, Providence, RI 02903 USA
[6] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA
来源
SHOCK | 2001年 / 16卷 / 06期
关键词
PGE(2); TNF-alpha; IL-1; beta; inflammation; immunomodulation;
D O I
10.1097/00024382-200116060-00013
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Studies indicate that trauma-hemorrhage results in activation of Kupffer cells to release inflammatory mediators and it leads to immunosuppression and increased susceptibility to subsequent sepsis. The cyclooxygenase (COX) product prostaglandin (PG) E-2 appears to be central to this process, however, non-selective inhibition of COX activity with non-steroidal anti-inflammatory agents that block both the constitutive (COX-1) and inducible (COX-2) isoforms of cyclooxygenase has not yielded promising results in trauma patients. Nonetheless, it remains unknown whether selective inhibition of COX-2 activity has any salutary effect following trauma-hemorrhage and subsequent induction of sepsis. To study this, male C3H/HeN mice were subjected to laparotomy (i.e., soft-tissue trauma) and hemorrhagic shock (35 +/- 5 mmHg for 90 min. then resuscitated) or to sham operation. Twenty-four hours later, the mice were subjected to sepsis by cecal ligation and puncture (CLP) or to sham CLP. The mice were treated with the COX-2 inhibitor NS-398 (10 mg/kg body weight, intraperitoneally) or vehicle immediately after trauma-hemorrhage or sham operation, 12 h thereafter, and following CLP or sham CLP. At 5 h after CLP, plasma PGE(2), Interleukin-(IL) 6, and TNF-alpha levels were determined along with Kupffer cell IL-6 and TNF-alpha production in vitro. NS-398 treatment markedly suppressed the elevation in plasma PGE(2) levels following CLP. The increase in plasma IL-6 levels after CLP were also significantly attenuated by NS-398 treatment. In vitro Kupffer cell IL-6 production after CLP was significantly reduced by in vivo NS-398 treatment. However, NS-398 had no effect on TNF-alpha levels, in vivo and in vitro. These findings indicate that activation of COX-2 following trauma-hemorrhage and subsequent sepsis up-regulates Kupffer cell IL-6 production. Thus, selective inhibition of COX-2 activity may reduce the deleterious consequences of sepsis under such conditions.
引用
收藏
页码:479 / 483
页数:5
相关论文
共 35 条
  • [1] Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis
    Anderson, GD
    Hauser, SD
    McGarity, KL
    Bremer, ME
    Isakson, PC
    Gregory, SA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) : 2672 - 2679
  • [2] DIFFERENTIAL-EFFECTS OF HEMORRHAGE ON KUPFFER CELLS - DECREASED ANTIGEN PRESENTATION DESPITE INCREASED INFLAMMATORY CYTOKINE (IL-1, IL-6 AND TNF) RELEASE
    AYALA, A
    PERRIN, MM
    ERTEL, W
    CHAUDRY, IH
    [J]. CYTOKINE, 1992, 4 (01) : 66 - 75
  • [3] AYALA A, 1994, ARCH SURG-CHICAGO, V129, P1172
  • [4] AYALA A, 1992, CIRC SHOCK, V36, P191
  • [5] AYALA A, 1996, SHOCK, V6, P27
  • [6] BAKER CC, 1983, SURGERY, V94, P331
  • [7] Ebong S, 1999, INFECT IMMUN, V67, P6603
  • [8] IBUPROFEN RESTORES CELLULAR-IMMUNITY AND DECREASES SUSCEPTIBILITY TO SEPSIS FOLLOWING HEMORRHAGE
    ERTEL, W
    MORRISON, MH
    MELDRUM, DR
    AYALA, A
    CHAUDRY, IH
    [J]. JOURNAL OF SURGICAL RESEARCH, 1992, 53 (01) : 55 - 61
  • [9] ERTEL W, 1991, BLOOD, V78, P1781
  • [10] BLOCKADE OF PROSTAGLANDIN PRODUCTION INCREASES CACHECTIN SYNTHESIS AND PREVENTS DEPRESSION OF MACROPHAGE FUNCTIONS AFTER HEMORRHAGIC-SHOCK
    ERTEL, W
    MORRISON, MH
    AYALA, A
    PERRIN, MM
    CHAUDRY, IH
    [J]. ANNALS OF SURGERY, 1991, 213 (03) : 265 - 271